Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a vanuatu marine sponge Pseudoceratina sp.

Marine Drugs

Volumn 7, Issue 4, 2009, Pages 640-653

  Lebouvier, Nicolas ^a   Jullian, Valérie ^b,c   Desvignes, Isabelle ^a   Maurel, Séverine ^b,c   Parenty, Arnaud ^a   Dorin Semblat, Dominique ^d,e   Doerig, Christian ^d,e   Sauvain, Michel ^b,c   Laurent, Dominique ^b,c  

^a UNIVERSITÉ DE LA NOUVELLE CALÉDONIE   (New Caledonia)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d EPFL   (Switzerland)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Homogentisic acid derivatives; Pfnek 1; Plasmodium falciparum; Pseudoceratina

Indexed keywords

11 DEOXYFISTULARIN 3; 11,19 DIDEOXYFISTULARIN 3; 2',4' DIBENZYLOXYACETAPHENONE; 4,6 DIBROMO 5 HYDROXY 3H BENZOFURAN 2 ONE; 6 BROMO 5 HYDROXY 3H BENZOFURAN 2 ONE; ANTIMALARIAL AGENT; DIBROMOVERONGIAQUINOL; HOMOGENTISIC ACID; METHYL(2,4 DIBROMO 3,6 DIHYDROXYPHENYL)ACETATE; METHYL(2,4 DIHYDROXYPHENYL)ACETATE; METHYL(2,5 DIHYDROXYPHENYL)ACETATE; METHYL(3,5 DIBROMO 2,4 DIHYDROXYPHENYL)ACETATE; METHYL(3,6 DIBENZOYL 2,4 DIBROMOPHENYL)ACETATE; METHYL(3,6 DIBENZOYL 4 BROMOPHENYL)ACETATE; METHYL(4 DIBROMO 3,6 DIHYDROXYPHENYL)ACETATE; PFNEK 1 PROTEIN; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; PSEUDOCERATINA; SPONGE (PORIFERA); VANUATU;

PLASMODIUM FALCIPARUM; PSEUDOCERATINA;

EID: 75149165314     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md7040640     Document Type: Article

References (35)

1. Laurent, D.; Pietra, F. Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria. A Review. Mar. Biotechnol. 2006, 8, 433-447.
2. Fattorusso, E.; Taglialatela-Scafati, O. Marine Antimalarials. Mar. Drugs 2009, 7, 130-152.
3. Gademann, K.; Kobylinska, J. Antimalarial natural products of marine and freshwater origin. Chem Rec. 2009, 9, 187-198.
4. Kaur, K.; Jain, M.; Kaur, T.; Jain R. Antimalarials from nature. Bioorg. Med. Chem. 2009, 17, 3229-3256.
5. Dorin, D.; Le Roch, K.; Sallicandro, P.; Alano, P.; Parzy, D.; Poullet, P.; Meijer, L.; Doerig, C. Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum. Eur. J. Biochem. 2001, 268, 2600-2608.
6. Laurent, D.; Jullian, V.; Parenty, A.; Knibiehler, M.; Dorin, D.; Schmitt, S.; Lozach, O.; Lebouvier, N.; Frostin, M.; Alby, F.; Maurel, S.; Doerig, C.; Meijer, L.; Sauvain, M. Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp. Bioorg. Med. Chem. 2006, 14, 4477-4482.
7. Takada, N.; Watanabe, R.; Suenaga, K.; Yamada, K.; Ueda, K.; Kita, M.; Uemura, D. Zamamistatin, a significant antibacterial bromotyrosine derivative, from the Okinawan sponge Pseudoceratina purpurea. Tetrahedron Lett. 2001, 42, 5265-5267.
8. Benharref, A.; Païs, M.; Debitus, C. Bromotyrosine Alkaloids from the Sponge Pseudoceratina verrucosa. J. Nat. Prod. 1996, 59, 177-180.
9. Tsukamoto, S.; Kato, H.; Hirota, H.; Fusetani, N. Ceratinamides A and B: New antifouling dibromotyrosine derivatives from the marine sponge Pseudoceratina purpurea. Tetrahedron 1996, 52, 181-186.
10. Kernan, M.R.; Cambie, R.C.; Bergquist, P.R., Chemistry of Sponges, VII. 11,19-Dideoxyfistularin 3 and 11-hydroxyaerothionin, bromotyrosine derivatives from Pseudoceratina durissima. J. Nat. Prod. 1990, 53, 615-622.
11. Piña, I.C.; Gautschi, J.T.; Wang, G.Y.; Sanders, M.L.; Schmitz, F.J.; France, D.; Cornell-Kennon, S.; Sambucetti, L.C.; Remiszewski, S.W.; Perez, L.B.; Bair, K.W.; Crews, P. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J. Org. Chem. 2003, 68, 3866-3873.
12. Aiello, A.; Fattorusso, E.; Menna, M.; Pansini, M., Chemistry of Verongida Sponges-V. Brominated metabolites from the Caribbean Sponge Pseudoceratina sp. Biochem. Syst. Ecol. 1995, 23, 377-381.
13. Fusetani, N.; Masuda, Y.; Nakao, Y.; Matsunaga, S.; van Soest, R.W.M. Three new bromotyrosine derivatives lethal to crab from the marine sponge, Pseudoceratina purpurea. Tetrahedron 2001, 57, 7507-7511.
14. Albrizio, S.; Ciminiello, P.; Fattorusso, E.; Magno, S.; Pansini, M. Chemistry of verongida sponges. I. Constituents of the Caribbean sponge Pseudoceratina crassa. Tetrahedron 1994, 50, 783-788.
15. Jang, J.-H.; Van Soest, R. W.M.; Fusetani, N.; Matsunaga, S. Pseudoceratins A and B, Antifungal Bicyclic Bromotyrosine-Derived Metabolites from the Marine Sponge Pseudoceratina purpurea. J. Org. Chem. 2007, 72, 1211-1217.
16. Schoenfeld, R.C.; Ganem, B. Synthesis of ceratinamine and moloka'iamine: Antifouling agents from the marine sponge Pseudoceratina purpurea. Tetrahedron Lett. 1998, 39, 4171-4150.
17. Buchanan, M.S.; Carroll, A.R.; Fechner, G.A.; Boyle, A.; Simpson, M.; Addepalli, R.; Avery, V.M.; Hooper, J.N.A.; Cheung, T.H.C.; Quinn, R.J. Aplysamine 6, an Alkaloidal Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase from the Sponge Pseudoceratina sp. J. Nat. Prod. 2008, 71, 1066-1067.
18. Thirionet, I.; Daloze, D.; Braekman, J.C.; Willemsen, P. 5-Bromoverongamine, a Novel Antifouling Tyrosine Alkaloid from the Sponge Pseudoceratina sp. Nat. Prod. Res. 1998, 12, 209-214.
19. Mancini, I.; Guella, G.; Laboute, P.; C., D.; Pietra, F. Hemifistularin 3: A degraded peptide or biogenetic precursor? Isolation from a sponge of the order verongida from the coral sea or generation from base treatment of 11-oxofistularin 3. J. Chem. Soc., Perkin Trans. 1 1993, 3121-3125.
20. Krejcarek, G.E.; White, R.H.; Hager, L.P.; McClure, W.O.; Johnson, R.D.; Rinehart, K.L.J.; McMillan, J.A.; Paul, J.C.; Shaw, P.D.; Brusca, R.C. A rearranged dibromotyrosine metabolite from Verongia aurea. Tetrahedron Lett. 1975, 16, 507-510.
21. Patil, A.D.; Westley, J.W.; Mattern, M.R.; Hofmann, G.A. Homogentisic acid derivatives, methods of treatment of disease states mediated by protein kinase C using homogentisic acid derivatives, and pharmaceutical compositions there of. 28 september 1995, 1995.
22. Krohn, K. Synthese des bactereostatischen 2.4-Dibrom- homogentisinsäureamidsund verwandter verbindungen. Tetrahedron Lett. 1975, 16, 4667-4668.
23. Abou-Shoer, M.I.; Shaala, L.A.; Youssef, D.T.A.; Badr, J.M.; Habib, A.-A.M. Bioactive Brominated Metabolites from the Red Sea Sponge Suberea mollis. J. Nat. Prod. 2008, 71, 1464-1467.
24. Desoubzdanne, D.; Marcourt, L.; Raux, R.; Chevalley, S.; Dorin, D.; Doerig, C.; Valentin, A.; Ausseil, F.; Debitus, C. Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a new caledonian deep water sponge. J. Nat. Prod. 2008, 71, 1189-1192.
25. Mbah, J.A.; Tane, P.; Ngadjui, B.T.; Connolly, J.D.; Okunji, C.C.; Iwu, M.M.; Schuster, B.M. Antiplasmodial agents from the leaves of Glossocalyx brevipes. Planta Med. 2004, 70, 437-440.
26. Kerr, T.J.; McHale, B.B. Applications in General Microbiology: A Laboratory Manual, 6th ed. Hunter Textbooks: Winston-Salem, NC, USA, 2001; p. 202-203.
27. Tilvi, S.; Rodrigues, C.; Naik, C.G.; Parameswaran, P.S.; Wahidhulla, S. New bromotyrosine alkaloids from the marine sponge Psammaplysilla purpurea. Tetrahedron 2004, 60, 10207-10215.
28. Yagi, H.; Matsunaga, S.; Fusetani, N. Purpuramines A-I, new bromotyrosine-derived metabolites from the marine sponge Psammaplysilla purpurea. Tetrahedron 1993, 49, 3749-3754.
29. Kobayashi, J.; Tsuda, M.; Agemi, K.; Shigemori, H.; Ishibashi, M.; Sasakia, T.; Mikamib, Y. Purealidins B and C, new bromotyrosine alkaloids from the okinawan marine sponge Psammaplysilla purea. Tetrahedron 1991, 47, 6617-6622.
30. Kim, D.; Lee, I.S.; Jung, J.H.; Yang, S.-I. Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. Arch. Pharm. Res. 1999, 22, 25-29.
31. Park, Y.; Liu, Y.; Hong, J.; Lee, C.-O.; Cho, H.; Kim, D.-K.; Im, K.S.; Jung, J.H. New bromotyrosine derivatives from an association of two sponges, Jaspis wondoensis and Poecillastra wondoensis. J. Nat. Prod. 2003, 66, 1495-1498.
32. Pick, N.; Rawat, M.; Arad, D.; Lan, J.; Fan, J.; Kende, A.S.; Av-Gay, Y. In vitro properties of antimicrobial bromotyrosine alkaloids. J. Med. Microbiol. 2006, 55, 407-415.
33. Matsunaga, S.; Kobayashi, H.; Van Soest, R.B.W.; Fusetani, N. Novel Bromotyrosine Derivatives That Inhibit Growth of the Fish Pathogenic Bacterium Aeromonas hydrophila, from a Marine Sponge Hexadella sp. J. Org. Chem. 2005, 70, 1893-1896.
34. Makler, M.T.; Hinrichs, D. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am. J. Trop. Med. Hyg. 1993, 48, 205-210.
35. Trager, W.; Jensen, J.B. Human malaria parasites in continuous culture. Science 1976, 193, 673-675.